267 related articles for article (PubMed ID: 15574621)
1. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.
Weinzimer SA; Ahern JH; Doyle EA; Vincent MR; Dziura J; Steffen AT; Tamborlane WV
Pediatrics; 2004 Dec; 114(6):1601-5. PubMed ID: 15574621
[TBL] [Abstract][Full Text] [Related]
2. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
[TBL] [Abstract][Full Text] [Related]
3. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
[TBL] [Abstract][Full Text] [Related]
4. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
6. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
Willi SM; Planton J; Egede L; Schwarz S
J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes.
Fox LA; Buckloh LM; Smith SD; Wysocki T; Mauras N
Diabetes Care; 2005 Jun; 28(6):1277-81. PubMed ID: 15920039
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective.
Mack-Fogg JE; Orlowski CC; Jospe N
Pediatr Diabetes; 2005 Mar; 6(1):17-21. PubMed ID: 15787897
[TBL] [Abstract][Full Text] [Related]
9. HbA
Evans-Cheung TC; Campbell F; Yong J; Parslow RC; Feltbower RG
Diabet Med; 2019 Jan; 36(1):88-95. PubMed ID: 30059173
[TBL] [Abstract][Full Text] [Related]
10. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes.
Wilson DM; Buckingham BA; Kunselman EL; Sullivan MM; Paguntalan HU; Gitelman SE
Diabetes Care; 2005 Jan; 28(1):15-9. PubMed ID: 15616227
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
Quirós C; Viñals C; Giménez M; Roca D; Conget I
Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
Alemzadeh R; Parton EA; Holzum MK
Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
[TBL] [Abstract][Full Text] [Related]
13. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.
Bode BW; Steed RD; Davidson PC
Diabetes Care; 1996 Apr; 19(4):324-7. PubMed ID: 8729154
[TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes.
Alemzadeh R; Ellis JN; Holzum MK; Parton EA; Wyatt DT
Pediatrics; 2004 Jul; 114(1):e91-5. PubMed ID: 15231979
[TBL] [Abstract][Full Text] [Related]
16. Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes.
Scrimgeour L; Cobry E; McFann K; Burdick P; Weimer C; Slover R; Chase HP
Diabetes Technol Ther; 2007 Oct; 9(5):421-8. PubMed ID: 17931050
[TBL] [Abstract][Full Text] [Related]
17. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.
Rizvi AA; Petry R; Arnold MB; Chakraborty M
Endocr Pract; 2001; 7(5):364-9. PubMed ID: 11585372
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia.
Sulli N; Shashaj B
J Pediatr Endocrinol Metab; 2003 Mar; 16(3):393-9. PubMed ID: 12705364
[TBL] [Abstract][Full Text] [Related]
20. Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service.
Rodrigues IA; Reid HA; Ismail K; Amiel SA
Diabet Med; 2005 Jul; 22(7):842-9. PubMed ID: 15975097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
